MétaCan
Menu
Back to cohort
Record W2793511964 · doi:10.1093/ecco-jcc/jjx180.978

P851 Oral delivery of Human β-defensin 2 is reversibly increasing microbiome diversity and is effective in the treatment of experimental colitis

2018· article· en· W2793511964 on OpenAlexaff
Louis Koeninger, Nicole Armbruster, Hu Zhang, Benjamin A. H. Jensen, Eduard F. Stange, Peter Nordkild, Nisar P. Malek, Lars Zender, Jan Wehkamp

Bibliographic record

VenueJournal of Crohn s and Colitis · 2018
Typearticle
Languageen
FieldAgricultural and Biological Sciences
TopicProbiotics and Fermented Foods
Canadian institutionsUniversité Laval
Fundersnot available
KeywordsDysbiosisUlcerative colitisColitisMicrobiomeImmunologyInflammatory bowel diseaseAntimicrobialBeta defensinDefensinDiseaseMedicineGut floraAntimicrobial peptidesImmune systemBiologyInnate immune systemBioinformaticsMicrobiologyInternal medicine

Abstract

fetched live from OpenAlex

Inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, are characterised by complex deficiencies of the mucosal antimicrobial barrier. Different epithelial secreted antimicrobial peptides protect the surface and regulate the gut luminal microbial community while ensuring a beneficial homeostasis. Disrupting this balance by an excessive or dysregulated immune response also results in a so-called “dysbiosis” but cause and consequence is still unclear. Independent of this causality debate, a decreased complexity and diversity of the gut microbiota are common features of chronic inflammation in IBD. The aim of this study was to translate these changes in disease understanding into a clear therapeutic approach. In detail, we tested the human host defence endogenous antimicrobial defensin in terms of (A) microbiome modulation and (B) therapeutic efficacy in experimental colitis. Mice were treated orally with a dose of 1.2 mg/kg per day for one week. Alterations in bacterial composition were analysed by next-generation sequencing on day 0, day 7 and day 14. Based on these results we tested the bacteriocidal and static effect of hBD2 on different commensal species using MIC in vitro. In a second approach, we tested oral administration of hBD2 in an experimental induced DSS colitis mouse model, compared with the standard therapy with prednisolone. Analysing the gut microbiome, a significant increase of diversity was observed during hBD2 treatment. Of note, these changes shift backwards after stopping the application. Hypothesis-driven MIC experiments were consistent with deep sequencing results of overall analysis. Testing the same dose in an experimental colitis model, the treatment resulted in a significantly lower weight loss (p < 0.05) and a strongly improved disease activity index (p < 0.001). Furthermore hBD2 reduced mucosal damage (p < 0.001). In this setting, the oral administration of hBD2 significantly improved the health in DSS colitis model. It seems that this effect is dependent on the ability of hBD2 to modulate the microbiome towards homeostasis.HBD2 shows promising effect in experimental DSS colitis model. The results and the better effect than prednisolone support a therapeutic application as a drug for IBD. These findings suggest the possibility of hBD2 be used alone or in combination with anti-inflammatory substances in microbiome associated diseases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.246
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicProbiotics and Fermented FoodsFrench-language works237,207